ASCO/ESMO 2020 Debio 1143/ Xevinapant Study Update

JanineT GRACE Community Outreach
GRACE Community Outreach Team

Here's another end of year review of new data.   Watch out, it's hopeful!


"Debio/ Xevinapant Study Update What Have We Learned About Debio 1143 (Xevinapant) in Combination with Chemoradiation Therapy for Patients With HNSCC?"

I joined GRACE as a caregiver for my husband who had a Pancoast tumor, NSCLC stage III in 2009. He had curative chemo/rads then it was believed he had a recurrence in the spine/oligometastasis that was radiated. He's 10 years out from treatment.